May 23-27: Who said What in Biotech and Pharmaceutical Industries?


These are some fresh promises that researchers and scientists made regarding their innovation and research and the collaborators filled us with the hope to take their business to a higher level and benefit the human race;

Quote 1.

Announcement is an important step towards the developing of our advanced cancer therapy systems”-Who said it? Answer is here

Quote 2.

We are pleased by the Advisory Committee’s recommendation for approval of this investigational diabetes therapy. By combining the complementary therapeutic effects of insulin glargine on fasting plasma glucose and of lixisenatide on postprandial plasma glucose, both of which can contribute to HbA1c lowering, this fixed-ratio product may address some of the unmet needs of adults living with type 2 diabetes who are considering initiating or intensifying insulin. We look forward to continuing to work with the FDA as it completes its reviews of these New Drug Applications”Who said it? Answer is here

Quote 3.

“With this asset purchase from Astellas and the creation of Thunderbolt, we are excited to begin to accelerate the development of the BAFF/APRIL dual antagonist program with the potential to deliver innovative treatments for patients with unmet needs”-Who said it? Answer is here

Quote 4.

Cytomegalovirus is the most important viral infection in hematopoietic stem cell transplant patients”-Who said it? Answer is here

Quote 5.

For a disease like Duchenne muscular dystrophy and other diseases that are highly debilitating and almost certainly fatal, we hope you will employ these flexibilities and considerations for the maximum benefit of patients who have no other alternative”-Who said it? Answer is here

Quote 6.

“Hillhurst is grateful to the NHLBI for recognizing the value of advancing the development of HBI-002. We believe our novel approach of targeting multiple mechanisms to prevent vaso-occlusive crises, including reducing inflammation, apoptosis, and sickling, holds great promise, which we believe is validated by this award”-Who said it? Answer is here

Quote 7.

As the first and only cell culture-derived seasonal influenza vaccine in the US to offer four-strain flu protection for people aged four years and older, Flucelvax Quadrivalent will provide healthcare providers and their patients with an important option to further broaden their influenza coverage”-Who said it? Answer is here

Quote 8.

The totality of the induction and maintenance data over the course of one year show the potential of this biologic therapy in inducing and maintaining a clinically relevant therapeutic effect in patients with moderate to severe Crohn’s disease. The results of this comprehensive Phase 3 program-which included anti-tumor necrosis factor (TNF)-alpha naïve, exposed and failure patients-demonstrate the potential of STELARA® to provide significant benefit for patients in need of an effective therapy”-Who said it? Answer is here

Quote 9.

Obtaining worldwide rights for interferon gamma-1b solidifies our continued investment in the medicine, and pending the outcome of clinical studies investigating it in Friedreich’s ataxia and advanced solid tumors, such as kidney and bladder cancer, strengthens our ability to expand its potential global use”-Who said it? Answer is here

Quote 10.

We are executing on a stated objective for 2016 of increasing the utilization of our tests in clinical trials and this agreement is our second with a major pharmaceutical company this year”-Who said it? Answer is here

Quote 11.

These trials will increase our understanding of heart failure, the patient population who may benefit from Entresto, and could potentially support applications to regulatory authorities”-Who said it? Answer is here

Quote 12.

On this 50th anniversary of the Animal Welfare Act, the USDA has at long last secured a penalty that is commensurate with the allegations”-Who said it? Answer is here


Leave a reply

Your email address will not be published. Required fields are marked *